Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
World Journal of Urology|May 26, 2025
Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer mythGabrielle Tissot, Pierre-Etienne Gabriel, Ulysse Dubuet, et al.
Arab Journal of Urology|March 25, 2021
Comparing oncological outcomes of laparoscopic vs open radical nephroureterectomy for the treatment of upper tract urothelial carcinoma: A propensity score-matched analysisMarco Moschini, Stefania Zamboni, Luca Afferi, et al.
World Journal of Urology|May 2, 2020
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaborationLuca Afferi, Stefania Zamboni, R Jeffrey Karnes, et al.
Minerva Urology and Nephrology|January 13, 2021
A comparison of perioperative outcomes of laparoscopic versus open nephroureterectomy for upper tract urothelial carcinoma: a propensity score matching analysisLuca Afferi, Mohammad Abufaraj, Francesco Soria, et al.
World Journal of Urology|April 30, 2022
Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomyAmandeep Arora, Ahmed S Zugail, Felipe Pugliesi, et al.
World Journal of Urology|November 24, 2020
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomesWojciech Krajewski, Marco Moschini, Joanna Chorbińska, et al.
Journal of Clinical Medicine|October 20, 2020
Restaging Transurethral Resection of Bladder Tumours after BCG Immunotherapy Induction in Patients with T1 Non-Muscle-Invasive Bladder Cancer Might not Be Associated with Oncologic BenefitWojciech Krajewski, Marco Moschini, Łukasz Nowak, et al.
Urologic Oncology|February 26, 2022
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?Alessia Cimadamore, Chiara Lonati, Ettore Di Trapani, et al.
European Urology Oncology|February 14, 2024
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, Wojciech Krajewski, Daniel A González-Padilla, et al.
BJU International|March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groupsAna Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
Pageof 6